2023
DOI: 10.1101/2023.06.30.547182
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Multifactorial analysis of terminator performance on heterologous gene expression in Physcomitrella

Paul Alexander Niederau,
Pauline Eglé,
Sandro Willig
et al.

Abstract: The production of recombinant proteins for health applications accounts for a large share of the biopharmaceutical market. While many drugs are produced in microbial and mammalian systems, plants gain more attention as expression hosts to produce eukaryotic proteins. In particular the GMP-compliant moss Physcomitrella (Physcomitrium patens) has outstanding features such as excellent genetic amenability, reproducible bioreactor cultivation, and humanized protein glycosylation patterns. In this study, we selecte… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 102 publications
0
2
0
Order By: Relevance
“…While most production hosts are vascular plants, such as Nicotiana benthamiana (Nicotiana) and Daucus carota (carrot), the non-vascular moss Physcomitrella has a proven track-record for the production of pharmaceuticals and bioactive ingredients (Decker and Reski, 2020;Verdú-Navarro et al, 2023;Munoz et al, 2024). In our attempts to constantly optimize this moss for molecular farming approaches (Reski et al, 2015;Ruiz-Molina et al, 2023), we concentrate on gene expression (e.g., Top et al, 2021;Niederau et al, 2024), bioproduction (e.g., Ruiz-Molina et al, 2022), and glycoengineering (e.g., Decker and Reski, 2012;Bohlender et al, 2022). In the latter field, plant-typical glyco-structures have been abolished (Parsons et al, 2012), and stable in-vivo protein sialylation has been achieved (Bohlender et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…While most production hosts are vascular plants, such as Nicotiana benthamiana (Nicotiana) and Daucus carota (carrot), the non-vascular moss Physcomitrella has a proven track-record for the production of pharmaceuticals and bioactive ingredients (Decker and Reski, 2020;Verdú-Navarro et al, 2023;Munoz et al, 2024). In our attempts to constantly optimize this moss for molecular farming approaches (Reski et al, 2015;Ruiz-Molina et al, 2023), we concentrate on gene expression (e.g., Top et al, 2021;Niederau et al, 2024), bioproduction (e.g., Ruiz-Molina et al, 2022), and glycoengineering (e.g., Decker and Reski, 2012;Bohlender et al, 2022). In the latter field, plant-typical glyco-structures have been abolished (Parsons et al, 2012), and stable in-vivo protein sialylation has been achieved (Bohlender et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…This involves combining these parts and quantifying the output reporter gene expression. While promoters are generally more well characterized, recently, attention has been also directed towards terminators; diverse arrays of terminators have been characterized in bacteria 16 , yeast 17 , and moss 18 . However, for plant systems the number of available terminator parts was limited for a long time, and their characterization was performed with the Nicotiana benthamiana leaf infiltration system 19,20 .…”
Section: Introductionmentioning
confidence: 99%